Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Austria Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20091
20103
20122
20131
20152
20171
20182
20193
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Bristol-Myers Squibb3
Eli Lilly and Company2
Abbott1
AstraZeneca1
Daiichi Sankyo1
Exelixis1
Hoffmann-La Roche1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Medical University of Vienna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular18
Liver Neoplasms5
Carcinoma4
Neoplasms2
Adenocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Hepatoblastoma1
Liver Diseases1
Neoplasms by Histologic Type1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.